limit use of PPIs (omeprazole, etc)

July 2010

See updated FDA information concerning the association of C. difficile and PPIs

You'll see more effort to limit use of PPIs (omeprazole, etc).

Over 50 million PPI Rxs a year are written for mild indigestion. And many patients end up taking them longer than needed.

Now the harms of PPI overuse are starting to hit home.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Controlled Substances Prescription Drug Monitoring Programs (PDMPs) to combat prescription drug abuse and diversion
Respiratory & Allergy whether it's okay to give beta-blockers to patients with chronic obstructive pulmonary disease (COPD)
Respiratory & Allergy alerts for interactions between salmeterol and strong CYP3A4 inhibitors... clarithromycin, itraconazole, ritonavir, etc
what lab tests are needed for certain drugs
Gastroenterology limit use of PPIs (omeprazole, etc)
Women's Health new oral contraceptive called Natazia (estradiol valerate/dienogest)
Vitamins & Minerals how much vitamin D is too much
Diabetes which diabetes patients should take aspirin
FDA will crack down on genetic tests marketed to consumers
Bites & Stings What really works to repel mosquitoes, ticks, and other insects
Neurology & Pain new warnings about tramadol abuse and suicide
Neurology & Pain more emphasis on using LOWER starting doses of hydromorphone (Dilaudid, etc)
Men's Health controversy about using testosterone in older men